Designing a digital patient avatar in the context of the MyHealthAvatar project initiative. - Evaggelia Maniadi; Haridimos Kondylakis; Emmanouil Spanakis; Marios Spanakis; Manolis Tsiknakis; Kostas Marias; Feng Dong 005 (BIBE, 2013)

Exploitation of patient avatars towards stratified medicine through the development of in silico clinical trials approaches. - Marios Spanakis; Efrosini Papadaki; Dimitris Kafetzopoulos; Apostolos Karantanas; Thomas G. Maris; Vangelis Sakkalis; Konstantinos Marias (BIBE, 2013)

Secure access to patient's health records using SpeechXRays a mutli-channel biometrics platform for user authentication. - Emmanouil G. Spanakis; Marios Spanakis; Apostolos Karantanas; Kostas Marias (EMBC, 2016)

Addressing drug-drug and drug-food interactions through personalized empowerment services for healthcare. - Marios Spanakis; Emmanouil G. Spanakis; Haridimos Kondylakis; Stelios Sfakianakis; Irini Genitsaridi; Vangelis Sakkalis; Manolis Tsiknakis; Kostas Marias (EMBC, 2016)

Developing a Context-Dependent Tuning Framework of Multi-channel Biometrics that Combine Audio-Visual Characteristics for Secure Access of an eHealth Platform. - Marios Spanakis; Georgios C. Manikis; Sakshi Porwal; Emmanouil G. Spanakis (MobiHealth, 2017)

PDCA: An eHealth service for the management of drug interactions with complementary and alternative medicines. - Marios Spanakis; Stelios Sfakianakis; Emmanouil G. Spanakis; George Kallergis; Vangelis Sakkalis (BHI, 2018)

Drugs with SMILES Similar to Coxibs. - George Kallergis; Stelios Sfakianakis; Michael E. Zervakis; Marios Spanakis (BIBE, 2019)

PharmActa: Personalized pharmaceutical care eHealth platform for patients and pharmacists. - Marios Spanakis; Stelios Sfakianakis; George Kallergis; Emmanouil G. Spanakis; Vangelis Sakkalis (J. Biomed. Informatics, 2019)

A Graph-Based Approach to Mitigate Drug-Drug Interactions and Optimize Therapeutic Regimens. - Marios Spanakis; Eleftheria Tzamali; Georgios Tzedakis; Emmanouil G. Spanakis; Aristides Tsatsakis; Vangelis Sakkalis (BIBE, 2023)